arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2408.02018cs.CVcs.AI
收藏

针对阿尔茨海默病的个体化多时间跨度 MRI 轨迹预测

Individualized multi-horizon MRI trajectory prediction for Alzheimer's Disease

University of California, Los Angeles(加州大学洛杉矶分校)

Rosemary He, Gabriella Ang, Daniel Tward

AI总结:

本文提出条件变分自编码器架构,基于年龄、疾病状态和既往 MRI 预测个体未来最长 10 年的脑影像轨迹,并在 ADNI 与 OASIS 上验证其个体化、高分辨率及疾病分类价值。

摘要:

通过磁共振成像(MRI)测量的神经退行性变被认为是诊断阿尔茨海默病(AD)的潜在生物标志物,但其特异性通常被认为低于基于淀粉样蛋白或 tau 蛋白的生物标志物。由于不同个体之间的脑解剖结构存在大量差异,我们假设利用 MRI 时间序列可以通过将每位患者作为其自身基线来帮助提高特异性。在此,我们采用条件变分自编码器,在给定受试者年龄、疾病状态和一次既往扫描的情况下生成个体化 MRI 预测。利用来自阿尔茨海默病神经影像学倡议(Alzheimer's Disease Neuroimaging Initiative)的连续成像数据,我们训练了一种新型架构,以构建一个潜在空间分布,可对其进行采样来生成不断变化的解剖结构的未来预测。这使我们能够外推到数据集之外,并预测最长达 10 年的 MRI。我们在 ADNI 的一个留出集以及一个独立数据集(来自 Open Access Series of Imaging Studies)上评估了该模型。通过与若干替代方法比较,我们表明模型能够生成更具个体化特征且分辨率更高的图像。此外,如果个体已有一次随访 MRI,我们展示了如何使用本模型计算用于疾病状态判断的似然比分类器。在实践中,该模型或许能够辅助 AD 的早期诊断,并为治疗效果估计提供反事实基线轨迹。此外,它还生成了一个合成数据集,可潜在用于异常检测和分类等下游任务。

英文摘要:

Neurodegeneration as measured through magnetic resonance imaging (MRI) is recognized as a potential biomarker for diagnosing Alzheimer's disease (AD), but is generally considered less specific than amyloid or tau based biomarkers. Due to a large amount of variability in brain anatomy between different individuals, we hypothesize that leveraging MRI time series can help improve specificity, by treating each patient as their own baseline. Here we turn to conditional variational autoencoders to generate individualized MRI predictions given the subject's age, disease status and one previous scan. Using serial imaging data from the Alzheimer's Disease Neuroimaging Initiative, we train a novel architecture to build a latent space distribution which can be sampled from to generate future predictions of changing anatomy. This enables us to extrapolate beyond the dataset and predict MRIs up to 10 years. We evaluated the model on a held-out set from ADNI and an independent dataset (from Open Access Series of Imaging Studies). By comparing to several alternatives, we show that our model produces more individualized images with higher resolution. Further, if an individual already has a follow-up MRI, we demonstrate a usage of our model to compute a likelihood ratio classifier for disease status. In practice, the model may be able to assist in early diagnosis of AD and provide a counterfactual baseline trajectory for treatment effect estimation. Furthermore, it generates a synthetic dataset that can potentially be used for downstream tasks such as anomaly detection and classification.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑